Drivers of HPV vaccine hesitancy in New York and Florida
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Merck & Co Inc (100933)
This publication has 21 references indexed in Scilit:
- Human Papillomavirus Vaccine Hesitancy in the United StatesPediatric Clinics of North America, 2023
- Factors related to human papillomavirus vaccine uptake and intentions among adults aged 18–26 and 27–45 years in the United States: A cross‐sectional studyCancer, 2023
- Associations of Maternal Age, Education, and Marital Status with HPV Vaccine Uptake and Hesitancy among United States Youth: A Cross-Sectional Analysis of the 2020 National Immunization SurveyJournal of Pediatric and Adolescent Gynecology, 2023
- An Update on Human Papillomavirus Vaccination in the United StatesObstetrics & Gynecology, 2023
- Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literatureHuman Vaccines & Immunotherapeutics, 2018
- Ten Years of Human Papillomavirus Vaccination in the United StatesAcademic Pediatrics, 2018
- Measuring vaccine hesitancy: The development of a survey toolVaccine, 2015
- Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012Vaccine, 2014
- Adolescent Understanding and Acceptance of the HPV Vaccination in an Underserved Population in New York CityJournal of Oncology, 2011
- General Methods for Monitoring Convergence of Iterative SimulationsJournal of Computational and Graphical Statistics, 1998